A2A Pharmaceuticals, Inc. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$805,500.13
Insider Sells Quantity
9
Insider Sells Sum
$26.55M

Insider Activity of A2A Pharmaceuticals, Inc.

Biography of A2A Pharmaceuticals, Inc.

No biography is available at this moment.

2023-06-01SaleBiomea Fusion, Inc.
BMEA
10 percent owner
50,000
0.1638%
$34.56$1.73M-57.49%
2023-05-31SaleBiomea Fusion, Inc.
BMEA
10 percent owner
75,000
0.2524%
$33.81$2.54M-55.29%
2023-05-12SaleBiomea Fusion, Inc.
BMEA
10 percent owner
25,000
0.0841%
$33.84$846,000-53.59%
2023-05-09SaleBiomea Fusion, Inc.
BMEA
10 percent owner
150,000
0.5185%
$34.50$5.18M-53.05%
2023-05-08SaleBiomea Fusion, Inc.
BMEA
10 percent owner
100,000
0.3445%
$33.99$3.4M-52.35%
2023-04-20SaleBiomea Fusion, Inc.
BMEA
10 percent owner
200,000
0.6723%
$29.12$5.82M-43.68%
2023-03-31SaleBiomea Fusion, Inc.
BMEA
10 percent owner
200,000
0.6812%
$31.25$6.25M-45.45%
2022-08-16PurchaseBiomea Fusion, Inc.
BMEA
30,684
0.1067%
$13.87$425,648-9.55%
2022-07-21SaleBiomea Fusion, Inc.
BMEA
34,658
0.1118%
$11.21$388,516-2.11%
2022-06-24SaleBiomea Fusion, Inc.
BMEA
34,658
0.1168%
$11.76$407,578-5.69%
2021-09-17PurchaseBiomea Fusion, Inc.
BMEA
10 percent owner
34,658
0.1193%
$10.96$379,852-20.13%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.